NL-OMON56135招募中不适用
Post Market Clinical Follow-up Study for the Amvia/Solvia Pacemaker Family - BIO|MASTER.Amvia study
BIOTRONIK SE and Co.KG0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Standard Indication for de novo, upgrade or replacement pacemaker or cardiac
- •resynchronization therapy pacemaker (CRT-P) implantation.
- •Ability and willingness to use the CardioMessenger and acceptance of the
- •BIOTRONIK Home Monitoring® concept.
排除标准
- •Planned for the usage of conduction system pacing
- •Planned cardiac surgical procedures or interventional measures other than the
- •study procedure within the next 12 months.
- •Age less than 18 years
研究者
相似试验
已完成
不适用
A post market clinical follow-up study with the artificial hip joint CBH Stem, with initial RSA analysiship arthroplastyhip replacement10023213NL-OMON47657Xpert Orthopedie150
撤回
不适用
Post market clinical follow-up study for the Pamira ICD lead family.cardiac arrhythmias10007521NL-OMON56034BIOTRONIK SE & Co.KG30
招募中
不适用
A post market clinical follow-up study with the aneXys ceramys inlay DEM16.7M16.1Other secondary coxarthrosisOther primary coxarthrosisDRKS00018809Mathys Orthopädie GmbH150
已完成
不适用
A post market clinical follow-up study with the aneXys acetabular cup and ceramys inlayM16.1M16.7Other primary coxarthrosisOther secondary coxarthrosisDRKS00021508Mathys AG Bettlach150
已完成
不适用
A post market clinical follow-up study with the Optimys Stem, with initial RSA analysisHip ArthroplastyHip replacement10023213NL-OMON47653Stichting SCORE150